berikova-e 1

1. Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial
2. Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis
3. Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial
1